About Andreu Prados

Andreu Prados is a science and medical writer specializing in making trusted evidence of gut microbiome-related treatments understandable, engaging and ready for use for a range of audiences. He holds bachelor’s degrees in Pharmacy and Human Nutrition and Dietetics and a PhD in nutrition communication. Follow Andreu on Twitter @andreuprados

The microorganisms that live in and on our body have been implicated in a variety of health functions and diseases. Two microbiologists comment on certain common assumptions about the human microbiota, including that it weighs 2 kg and is altered in case of obesity.

Differences in the gut microbiota in patients with IBD compared to healthy controls suggest that probiotics may be of help. This article takes an in-depth look into the rationale of using probiotics for IBD and summarizes the evidence from recent clinical guidelines for the use of probiotics in Crohn’s disease, ulcerative colitis and pouchitis.

The DDW meeting 2023 covered a huge variety of basic, translational and clinical aspects of research in gastrointestinal and extraintestinal human health and disease. This post highlights the major-takeaways from the Microbiome & Microbial Therapy sessions and unravels how they might impact daily basic research and clinical practice (part 1).

Probiotics are commonly used in clinical practice for digestive ailments. Some clinical trials also support the use of specific probiotics, taken orally or vaginally, for restoring the vaginal microbiota and managing bacterial vaginosis and vulvovaginal candidiasis. Here’s what we know.